Brief: IX Biopharma says entered into placement agreement
14/04/2016 12:57
April 14 (Reuters) - IX Biopharma Ltd IXBI.SI : * Says entered into a placement agreement * Says agreement with Cimb Securities (Singapore) pte. ltd * Says aggregate consideration of approximately s$5.03 million * Company will raise net cash proceeds of approximately s$4.84 million from the placement * Says placement agreement at aggregate of 14.4 million new ordinary shares in the capital of the company at an issue price of s$0.35 * Net proceeds will be used for registration of co's products with appropriate agencies for approval to sell the products * Source text for Eikon ID:nSNZ16XDB2 * ((For more news, please click here IXBI.SI )) ((Bengaluru Newsroom; +91 806749 1130))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture